Neuroendokrines Karzinom des Analkanals: eine seltene Differenzialdiagnose – Sicht des Pathologen

Jasmin C. Riemer; Andreas Krieg; Dirk Graf; Wolfram T. Knoefel; Irene Esposito

doi:10.1055/s-0042-124582

TumorDiagnostik & Therapie, Table of Contents

TumorDiagnostik & Therapie 2017; 38(01): 56-60
DOI: 10.1055/s-0042-124582

Thieme Onkologie aktuell

Neuroendokrines Karzinom des Analkanals: eine seltene Differenzialdiagnose – Sicht des Pathologen

Jasmin C. Riemer

¹Institut für Pathologie, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität Düsseldorf

,

Andreas Krieg

²Klinik für Allgemein-, Viszeral- und Kinderchirurgie, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität Düsseldorf

,

Dirk Graf

³Klinik für Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität Düsseldorf

,

Wolfram T. Knoefel

²Klinik für Allgemein-, Viszeral- und Kinderchirurgie, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität Düsseldorf

,

Irene Esposito

¹Institut für Pathologie, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität Düsseldorf

› Author Affiliations

Abstract

Full Text

References

Literatur
1 Dawson H. Serra S. Tumours and inflammatory lesions of the anal canal and perianal skin revisited: an update and practical approach. J Clin Pathol 2015; 68: 971-981
2 Metildi C. McLemore EC. Tran T. et al. Incidence and survival patterns of rare anal canal neoplasms using the surveillance epidemiology and end results registry. Am Surg 2013; 79: 1068-1074
3 Yao JC. Hassan M. Phan A. et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008; 26: 3063-3072
4 Bosman FT. Caneiro F. Hruban RH. et al. WHO classification of tumours of the digestive system. Lyon: IARC Press; 2010
5 Uronis HE. Bendell JC. Anal cancer: an overview. Oncologist 2007; 12: 524-534
6 Skelton HG. Smith KJ. Hitchcock CL. et al. Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol 1997; 37: 734-739
7 Nehal KS. Levine VJ. Ashinoff R. Basal cell carcinoma of the genitalia. Dermatologic surgery: official publication for American Society for Dermatologic Surgery [et al] 1998; 24: 1361-1363
8 Rindi G. Kloppel G. Couvelard A. et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2007; 451: 757-762
9 Niederle MB. Hackl M. Kaserer K. et al. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocr Relat Cancer 2010; 17: 909-918
10 Miederer M. Seidl S. Buck A. et al. Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT. Eur J Nucl Med Mol Imaging 2009; 36: 48-52
11 Ahlman H. Nilsson O. McNicol AM. et al. Poorly-differentiated endocrine carcinomas of midgut and hindgut origin. Neuroendocrinology 2008; 87: 40-46
12 Caplin M. Sundin A. Nillson O. et al. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. Neuroendocrinology 2012; 95: 88-97